This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Leadiant Biosciences Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Santosh Kumar Ramamurthy: Innovator in Fibrosis Treatment
Introduction
Santosh Kumar Ramamurthy is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of medical treatments, particularly in addressing conditions related to fibrosis and scleroderma. His innovative work has led to the development of a patent that holds promise for improving patient outcomes.
Latest Patents
Ramamurthy holds a patent for "Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma." This patent includes compositions containing Adenosine Deaminase (ADA) or polypeptides with ADA activity. The methods described aim to prevent and treat scleroderma-associated vasculopathy, including various forms of obliterative vasculopathy. His work is crucial in the fight against scleroderma, which can significantly impact patients' quality of life.
Career Highlights
Throughout his career, Ramamurthy has worked with several companies, including Leadiant Biosciences Ltd. and Unikeris Limited. His experience in these organizations has allowed him to refine his expertise in developing therapeutic solutions for complex medical conditions.
Collaborations
Ramamurthy has collaborated with notable professionals in his field, including Gianfranco Fornasini and Nadejda Soukhareva. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Santosh Kumar Ramamurthy is a distinguished inventor whose work in treating fibrosis and scleroderma has the potential to make a significant impact on patient care. His innovative approaches and collaborations highlight the importance of continued research in this vital area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile